XTAMPZA ER FDA approval date
The FDA approved XTAMPZA ER on 26 Apr 2016.
- FDA approval date
- 26 Apr 2016
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as OXYCODONE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2016-04-26Day | XTAMPZA ER | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA208090", "applicant_as_listed_by_fda": "COLLEGIUM PHARM INC", "brand_names": ["XTAMPZA ER"], "active_ingredients": ["OXYCODONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160426", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |